138 related articles for article (PubMed ID: 16337995)
1. Weekly gemcitabine and cisplatin in combination with pelvic radiation in the primary therapy of cervical cancer: a phase I trial of the Puget Sound Oncology Consortium.
; Swisher EM; Swensen RE; Greer B; Tamimi H; Goff BA; Garcia R; Koh WJ
Gynecol Oncol; 2006 Jun; 101(3):429-35. PubMed ID: 16337995
[TBL] [Abstract][Full Text] [Related]
2. Weekly gemcitabine and cisplatin concurrent with pelvic irradiation for primary therapy of cervical cancer: report of the first seven cases in Thai women.
Chumworathayi B; Yuenyao P; Tangvorapongchai V; Luanratanakorn S; Pattamadilok J; Krusun S
Radiat Med; 2007 Nov; 25(9):474-9. PubMed ID: 18026906
[TBL] [Abstract][Full Text] [Related]
3. Phase 1 Trial of Concurrent Gemcitabine and Cisplatin with Image Guided Intensity Modulated Radiation Therapy for Locoregionally Advanced Cervical Carcinoma.
Mell LK; Xu R; Yashar CM; McHale MT; Einck JP; Mayadev J; Lee E; Binder P; Rash D; Eskander R; Heide ES; Plaxe SC; Mundt AJ; Saenz CC
Int J Radiat Oncol Biol Phys; 2020 Aug; 107(5):964-973. PubMed ID: 32334034
[TBL] [Abstract][Full Text] [Related]
4. A phase I study of gemcitabine followed by cisplatin concurrent with whole pelvic radiation therapy in locally advanced cervical cancer: a Gynecologic Oncology Group study.
Rose PG; Degeest K; McMeekin S; Fusco N
Gynecol Oncol; 2007 Nov; 107(2):274-9. PubMed ID: 17688925
[TBL] [Abstract][Full Text] [Related]
5. Phase I clinical trial of weekly paclitaxel, weekly carboplatin, and concurrent radiotherapy for primary cervical cancer.
Rao GG; Rogers P; Drake RD; Nguyen P; Coleman RL
Gynecol Oncol; 2005 Jan; 96(1):168-72. PubMed ID: 15589596
[TBL] [Abstract][Full Text] [Related]
6. Concurrent cisplatin/gemcitabine chemotherapy along with radiotherapy in locally advanced cervical carcinoma: a phase II trial.
Umanzor J; Aguiluz M; Pineda C; Andrade S; Erazo M; Flores C; Santillana S
Gynecol Oncol; 2006 Jan; 100(1):70-5. PubMed ID: 16288803
[TBL] [Abstract][Full Text] [Related]
7. A phase I-II study of weekly cisplatin and gemcitabine with concurrent radiotherapy in locally advanced cervical carcinoma.
Zarbá JJ; Jaremtchuk AV; Gonzalez Jazey P; Keropian M; Castagnino R; Mina C; Arroyo G;
Ann Oncol; 2003 Aug; 14(8):1285-90. PubMed ID: 12881394
[TBL] [Abstract][Full Text] [Related]
8. Phase III, open-label, randomized study comparing concurrent gemcitabine plus cisplatin and radiation followed by adjuvant gemcitabine and cisplatin versus concurrent cisplatin and radiation in patients with stage IIB to IVA carcinoma of the cervix.
Dueñas-González A; Zarbá JJ; Patel F; Alcedo JC; Beslija S; Casanova L; Pattaranutaporn P; Hameed S; Blair JM; Barraclough H; Orlando M
J Clin Oncol; 2011 May; 29(13):1678-85. PubMed ID: 21444871
[TBL] [Abstract][Full Text] [Related]
9. A phase I study of concurrent weekly topotecan and cisplatin chemotherapy with whole pelvic radiation therapy in locally advanced cervical cancer: a gynecologic oncology group study.
Rose PG; Sill MW; McMeekin DS; Ahmed A; Salani R; Yamada SD; Wolfson AH; Fusco N; Fracasso PM
Gynecol Oncol; 2012 Apr; 125(1):158-62. PubMed ID: 22198338
[TBL] [Abstract][Full Text] [Related]
10. Prospective randomized comparison of monthly fluorouracil and cisplatin versus weekly cisplatin concurrent with pelvic radiotherapy and high-dose rate brachytherapy for locally advanced cervical cancer.
Kim YS; Shin SS; Nam JH; Kim YT; Kim YM; Kim JH; Choi EK
Gynecol Oncol; 2008 Jan; 108(1):195-200. PubMed ID: 17963825
[TBL] [Abstract][Full Text] [Related]
11. A phase II trial of less than 7 weeks of concomitant cisplatin-paclitaxel chemoradiation in locally advanced cervical cancer.
Martínez-Monge R; Gaztañaga M; Aramendía JM; Cambeiro M; Arbea L; Espinós J; Aristu JJ; Jurado M
Int J Gynecol Cancer; 2010 Jan; 20(1):133-40. PubMed ID: 20130514
[TBL] [Abstract][Full Text] [Related]
12. Phase I study of irinotecan and cisplatin in combination with pelvic radiotherapy in the treatment of locally advanced cervical cancer: A GINECO trial.
Fabbro M; Gladieff L; Guichard F; El Demery M; Dalenc F; Kerr C; Delannes M; Paraiso D; Pujade-Lauraine E; Kurtz JE
Gynecol Oncol; 2010 May; 117(2):276-80. PubMed ID: 20226502
[TBL] [Abstract][Full Text] [Related]
13. Phase I study with weekly cisplatin-paclitaxel and concurrent radiotherapy in patients with carcinoma of the cervix uteri.
Pignata S; Frezza P; Tramontana S; Perrone F; Tambaro R; Casella G; Ferrari E; Iodice F; De Vivo R; Ricchi P; Tramontana F; Silvestro G
Ann Oncol; 2000 Apr; 11(4):455-9. PubMed ID: 10847466
[TBL] [Abstract][Full Text] [Related]
14. A randomized trial comparing concurrent chemoradiotherapy with single-agent cisplatin versus cisplatin plus gemcitabine in patients with advanced cervical cancer: An Asian Gynecologic Oncology Group study.
Wang CC; Chou HH; Yang LY; Lin H; Liou WS; Tseng CW; Liu FY; Liou JD; Huang KG; Huang HJ; Huang EY; Chen CH; Chang TC; Chang CJ; Hong JH; Lai CH
Gynecol Oncol; 2015 Jun; 137(3):462-7. PubMed ID: 25827291
[TBL] [Abstract][Full Text] [Related]
15. A feasibility study of topotecan with standard-dose cisplatin and concurrent primary radiation therapy in locally advanced cervical cancer.
Gatcliffe TA; Tewari KS; Shah A; Brewster WR; Burger RA; Kuo JV; Monk BJ
Gynecol Oncol; 2009 Jan; 112(1):85-9. PubMed ID: 18977518
[TBL] [Abstract][Full Text] [Related]
16. Phase one dose finding study of capecitabine (Xeloda), radiotherapy and cisplatin in the treatment of locally advanced squamous cervical cancer.
Stokes Z; Symonds P; Habeshaw T; Reed N; Curto J; Joynson C; Chan S
Gynecol Oncol; 2005 Jun; 97(3):790-5. PubMed ID: 15894361
[TBL] [Abstract][Full Text] [Related]
17. Highly conformal combined radiotherapy with cisplatin and gemcitabine for treatment of loco-regionally advanced cervical cancer - a retrospective study.
Cihoric N; Tsikkinis A; Vlaskou Badra E; Glatzer M; Novak U; Scherz A; Shelan M; Soldatovic I; Yojena CKK; Aebersold DM; Lössl K
Radiat Oncol; 2017 Dec; 12(1):202. PubMed ID: 29273076
[TBL] [Abstract][Full Text] [Related]
18. Phase II study of concurrent gemcitabine and radiotherapy in locally advanced stage IIIB cervical carcinoma.
Pattaranutaporn P; Thirapakawong C; Chansilpa Y; Therasakvichya S; Ieumwananontachai N; Thephamongkhol K
Gynecol Oncol; 2001 Jun; 81(3):404-7. PubMed ID: 11371129
[TBL] [Abstract][Full Text] [Related]
19. Chemoradiation in cervical cancer with cisplatin and high-dose rate brachytherapy combined with external beam radiotherapy. Results of a phase-II study.
Strauss HG; Kuhnt T; Laban C; Puschmann D; Pigorsch S; Dunst J; Koelbl H; Haensgen G
Strahlenther Onkol; 2002 Jul; 178(7):378-85. PubMed ID: 12163992
[TBL] [Abstract][Full Text] [Related]
20. Pathologic response and toxicity assessment of chemoradiotherapy with cisplatin versus cisplatin plus gemcitabine in cervical cancer: a randomized Phase II study.
Dueñas-González A; Cetina-Perez L; Lopez-Graniel C; Gonzalez-Enciso A; Gómez-Gonzalez E; Rivera-Rubi L; Montalvo-Esquivel G; Muñoz-Gonzalez D; Robles-Flores J; Vazquez-Govea E; de La Garza J; Mohar A
Int J Radiat Oncol Biol Phys; 2005 Mar; 61(3):817-23. PubMed ID: 15708261
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
